Condition: Nasal Obstruction Due to Inferior Turbinate Hypertrophy · Sponsor: Smith & Nephew, Inc.
The study is a prospective, multi-center, post-market clinical study to evaluate the safety and effectiveness of REFLEX ULTRA 45 for the coblation inferior turbinate reduction in China. The study product is REFLEX ULTRA 45 (EIC4845-01/EICA4845-01). Also it needs to be performed with the controller system COBLATOR II or WEREWOLF. The sample size is 105 subjects with approximate 6 sites in China mainland.
This description comes directly from the study's public registry record.
Cathy Xiao · +86 18221637315 · Cathy.xiao@smith-nephew.com
Julian Yang · +86 18101802151 · Julian.yang@smith-nephew.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital, Sun Yat-sen University | Guangzhou, Guangdong, China | Recruiting |
| The Third Affiliated Hospital, Sun Yat-sen University | Guangzhou, Guangdong, China | Recruiting |
| Henan Provincial People's Hospital | Zhengzhou, Henan, China | Recruiting |
| Jiangsu Province Hospital | Nanjing, Jiangsu, China | Recruiting |
| China-Japan Union Hospital of Jilin University | Changchun, Jilin, China | Recruiting |
| Sir Run Run Shaw Hospital Affiliated with Zhejiang University School of Medicine | Hangzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07025304